ClinicalTrials.Veeva

Menu

Biomarkers of Early Chronic Obstructive Pulmonary Disease (COPD) in Smokers - Longitudinal Study

L

Lund University

Status

Completed

Conditions

Chronic Obstructive Pulmonary Disease
Lung Cancer
Cardiovascular Disease

Study type

Observational

Funder types

Other

Identifiers

NCT02076061
KOL 001

Details and patient eligibility

About

This is a longitudinal observational study to identify and validate protein biomarkers for COPD (chronic obstructive pulmonary diseases) and cardiovascular disease in smokers and ex-smokers attending primary care. Special emphasize is to correlate biomarkers to different phases of COPD, to progression of the disease, and to treatment of the disease. Furthermore, linkage between COPD, cardiovascular disease, and lung cancer will be investigated by identifying protein biomarkers.

Enrollment

300 patients

Sex

All

Ages

35 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Diagnosed with COPD Gold stage 0-IV

Exclusion criteria

Patients with inflammatory diseases Patients with cancer Patients using immune system regulating drugs

Trial design

300 participants in 6 patient groups

GOLD stage I
GOLD Stage II
GOLD Stage III
GOLD Stage IV
Smokers/ex-smokers w/o COPD
non-Smokers w/o COPD

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems